ZENPEP: payments to doctors
Payments that named ZENPEP as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8M
- Providers
- 33,982
- Transactions
- 167,547
- Average per transaction
- $48
The per-transaction average — $48 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 33,982 providers the average total is $237, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aimmune Therapeutics, Inc. | $3,891,080 | 48.3% |
| Nestle Healthcare Nutrition Inc. | $3,521,986 | 43.8% |
| AbbVie | $635,373 | 7.9% |